Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita

Epidermolysis bullosa acquisita (EBA) is a muco-cutaneous autoimmune disease characterized and caused by autoantibodies targeting type VII collagen (COL7). The treatment of EBA is notoriously difficult, with a median time to remission of 9 months. In preclinical EBA models, we previously discovered...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Natalie Gross, Jana Marketon, Sadegh Mousavi, Kathrin Kalies, Ralf J. Ludwig, Katja Bieber
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-05-01
Colecção:	Frontiers in Immunology
Assuntos:	epidermolysis bullosa acquisita treatment neutrophils model system pemphigoid IFN-γ
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1343299/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!